Eleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just Sanofi, as part of a ...

In trading Monday afternoon, shares of Genzyme rose $2.05, or 2.9 percent, to $73.15, while U.S.-traded shares of Sanofi added 88 cents to $34.23. Typically, due diligence can take weeks or months.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, ... Sanofi Genzyme priced Dupixent at $37,000 per patient, ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile ...

With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in the life sciences industry. Genzyme received a $14.3 million grant from the Massachusetts ...

With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in the life sciences industry. Genzyme received a $14.3 million grant from the Massachusetts ...

Sanofi Genzyme will lay off 130 workers this week at its manufacturing plant in Boston in an effort to reduce costs and simplify operations, according to the Boston Globe. Skip to main content BHR ...

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right Combination will ... France and Cambridge, Massachusetts - February 16, 2011 /PRNewswire ...

French pharmaceutical group Sanofi-Aventis unveiled on August 29 an $18.5 billion offer for U.S. biotechnology firm Genzyme, hinting it may launch a hostile bid. The non-binding cash offer of $69 per ...

While Sanofi's just-announced reorganization will bring new drugs, and possibly new employees, to Genzyme, one casualty of the changes may be the name.

To be fair, many people long ago stopped using the Genzyme name in Massachusetts (although it’s visible in the lobby of Sanofi’s building at 50 Binney St. in Cambridge).

Sanofi Genzyme's new president, ... Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold.